Citations

Showing 10 of 108104 citations.

Inflammatory Cells in Nephrectomy Tissue from Patients without and with a History of Urinary Stone Disease
Dejban, Pegah, Wilson, Elena , Jayachandran, Muthuvel , Hernandez, Loren P. Herrera , Haskic, Zejfa , Wellik, Linda, Rule, Andrew D. , Đenić, Aleksandar , Koo, Kevin , Potretzke, Aaron M. , Wilson, Elena M , Herrera Hernandez, Loren P, Wellik, Linda E, Rule, Andrew D , Denic, Aleksandar , Sinha, Sutapa , Lieske, John C.

Mayo Clinic

Clinical Journal of the American Society of Nephrology | January 25, 2022 | Volume: 17 | Issue: 3 | Pages: 414-422

10.2215/cjn.11730921 | PMID 35078782 Get It

Background and objectives Urinary stone disease has been associated with inflammation, but the specific cell interactions that mediate events remain poorly defined. This study compared calcification and inflammatory cell patterns in kidney tissue from radical nephrectomy specimens of patients without and with a history of urinary stone disease. Design, setting, participants, & measurements Nontumor parenchyma of biobanked radical nephrectomy specimens from age- and sex-matched stone formers ( n =44) and nonstone formers ( n =82) were compared. Calcification was detected by Yasue staining and inflammatory cell populations by immunohistochemistry for CD68 (proinflammatory M1 macrophages), CD163 and CD206 (anti-inflammatory M2 macrophages), CD3 (T lymphocytes), and tryptase (mast cells). Calcifications and inflammatory cells were quantified in cortex and medulla using Image-Pro analysis software. Results Calcification in the medulla of stone formers was higher than in nonstone formers ( P <0.001). M1 macrophages in the cortex and medulla of stone formers were greater than in nonstone formers ( P <0.001), and greater in stone former medulla than stone former cortex ( P =0.02). There were no differences in age, sex, body mass index, tumor characteristics (size, stage, or thrombus), vascular disease status, or eGFR between the groups. M2 macrophages, T lymphocytes, and mast cells did not differ by stone former status. There was a correlation between M1 macrophages and calcification in the medulla of stone formers (rho=0.48; P =0.001) and between M2 macrophages and calcification in the medulla of nonstone formers (rho=0.35; P =0.001). T lymphocytes were correlated with calcification in the cortex of both nonstone formers (rho=0.27; P =0.01) and stone formers (rho=0.42; P =0.004), whereas mast cells and calcification were correlated only in the cortex of stone formers (rho=0.35; P =0.02). Conclusions Higher medullary calcification stimulated accumulation of proinflammatory rather than anti-inflammatory macrophages in stone formers.
Radiation necrosis in renal cell carcinoma brain metastases treated with checkpoint inhibitors and radiosurgery: An international multicenter study
Lehrer, Eric J. , Gurewitz, Jason , Bernstein, Kenneth , Patel, Dev , Niranjan, Ajay , Wei, Zhishuo , Lunsford, L. Dade , Malouff, Timothy D. , Patel, Samir , Bonney, Phillip A. , Hwang, Lindsay , Yu, Cheng , Zada, Gabriel , Mathieu, David , Trudel, Claire, Prasad, Rahul N. , Sharma, Sonam , Fakhoury, Kareem , Rusthoven, Chad G. , Deibert, Christopher P., Picozzi, Piero , Franzini, Andrea , Attuati, Luca , Lee, Cheng‐Chia , Ahluwalia, Manmeet S. , Sheehan, Jason P. , Trifiletti, Daniel M , Mathieu, David , Ahluwalia, Manmeet S , Patel, Dev, Kondziolka, Douglas , Ruiz-García, Henry , Palmer, Joshua D. , Jones, Brianna M. , Yang, Huai‐Che , Trifiletti, Daniel M.

Mayo Clinic

Cancer | January 25, 2022 | Volume: 128 | Issue: 7 | Pages: 1429-1438

10.1002/cncr.34087 | PMID 35077586 Get It

BACKGROUNDPatients with renal cell carcinoma (RCC) brain metastases are frequently treated with immune checkpoint inhibitors (ICIs) and stereotactic radiosurgery (SRS). However, data reporting on the risk of developing radiation necrosis (RN) are limited.METHODSRN rates were compared for concurrent therapy (ICI/SRS administration within 4 weeks of one another) and nonconcurrent therapy with the χ2 test. Univariable logistic regression was used to identify factors associated with developing RN.RESULTSFifty patients (23 concurrent and 27 nonconcurrent) with 395 brain metastases were analyzed. The median follow‐up was 12.1 months; the median age was 65 years. The median margin dose was 20 Gy, and 4% underwent prior whole‐brain radiation therapy (WBRT). The median treated tumor volume was 3.32 cm3 (range, 0.06‐42.38 cm3); the median volume of normal brain tissue receiving a dose of 12 Gy or higher (V12 Gy) was 8.42 cm3 (range, 0.27‐111.22 cm3). Any‐grade RN occurred in 17.4% and 22.2% in the concurrent and nonconcurrent groups, respectively (P = .67). Symptomatic RN occurred in 4.3% and 14.8% in the concurrent and nonconcurrent groups, respectively (P = .23). Increased tumor volume during SRS (odds ratio [OR], 1.08; 95% confidence interval [CI], 1.01‐1.19; P = .04) was associated with developing RN, although V12 Gy (OR, 1.03; 95% CI, 0.99‐1.06; P = .06), concurrent therapy (OR, 0.74; 95% CI, 0.17‐2.30; P = .76), prior WBRT, and ICI agents were not statistically significant.CONCLUSIONSSymptomatic RN occurs in a minority of patients with RCC brain metastases treated with ICI/SRS. The majority of events were grade 1 to 3 and were managed medically. Concurrent ICI/SRS does not appear to increase this risk. Attempts to improve dose conformality (reduce V12) may be the most successful mitigation strategy in single‐fraction SRS.
Delphi Method Consensus on Priority Global Otolaryngology–Head and Neck Surgery Conditions and Procedures
Nuss, Sarah , Patterson, Rolvix H. , Cahill, Gabrielle , Alkire, Blake C., Xu, Mary Jue , Salano, Valerie , Wiedermann, Josh, Okerosi, Samuel , Patterson, Rolvix H

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 25, 2022 | Volume: 167 | Issue: 4 | Pages: 669-677

10.1177/01945998211073705 | PMID 35077240 Get It

ObjectiveThe objective of this study was to develop an international expert consensus on priority otolaryngology–head and neck surgery conditions and procedures globally for which national health systems should be capable of caring.Study DesignThe Delphi method was employed via a multiround online survey administered to attending otolaryngologists in an international research collaborative of >180 otolaryngologists in >40 countries.SettingInternational online survey.MethodsIn round 1, participants listed the top 15 otolaryngologic conditions and top 15 otolaryngology procedures for their World Bank regions. In round 2, participants ranked round 1 responses in order of global importance on a 5‐point Likert scale. In round 3, participants reranked conditions and procedures that did not achieve consensus, defined as 50% of the round 2 Likert responses being ranked as “important” or “very important.” Descriptive statistics were calculated for each round.ResultsThe survey was distributed to 53 experts globally, with a response rate of 38% (n = 20). Fifty percent (n = 10) of participants were from low‐ and middle‐income countries, with at least 1 participant from each World Bank region. Ten consensus surgical procedures and 10 consensus conditions were identified.ConclusionThis study identified a list of priority otolaryngology–head and neck surgery conditions and surgical procedures for which all national health systems around the world should be capable of managing. Acute and infectious conditions with preventative and emergent procedures were highlighted. These findings can direct future research and guide international collaborations.
Recurrence Following Endoscopic Laser Wedge Excision and Triple Medical Therapy for Idiopathic Subglottic Stenosis
Bowen, Andrew J. , Xie, Katherine , O’Byrne, Thomas J., Bayan, Semirra L. , Edell, Eric S. , Vassallo, Robert , Ekbom, Dale C. , Kasperbauer, Jan L. , Bowen, Andrew Jay , Xie, Katherine Z , Vassallo, Robert , Bayan, Semirra

Mayo Clinic

Otolaryngology–Head and Neck Surgery | January 25, 2022 | Volume: 167 | Issue: 3 | Pages: 524-530

10.1177/01945998221074684 | PMID 35077239 Get It

ObjectiveWe present the outcomes for patients with idiopathic subglottic stenosis (iSGS) following their first carbon dioxide laser wedge excision (LWE) procedure, additionally examining the effect of compliance with adjuvant medical therapy (triple therapy) after the operation.Study DesignRetrospective chart review.SettingTertiary center.MethodsA retrospective review was performed on 183 patients with iSGS following their first LWE and their compliance to adjuvant medical therapy (inhaled corticosteroid, proton pump inhibitor, trimethoprim‐sulfamethoxazole) following the operation, with all reviewed to December 31, 2020. The primary outcome variable was median time to recurrence (MTR). Patients were stratified by whether the LWE was their first operation (LWE primary or secondary), by compliance to triple therapy, and by compliance with trimethoprim‐sulfamethoxazole. Kaplan‐Meier analysis and Cox proportional hazards were used to evaluate the MTR across the stratifications.ResultsAn overall 113 patients underwent their first LWE, while 70 received the procedure after having undergone 1 to 13 procedures. The MTR between LWE primary and secondary was 4.6 and 2.9 years, respectively. Adjusted Cox proportional hazards comparing these 2 groups revealed the number of prior operations to be a confounding variable. A statistically increased MTR was demonstrated with greater degrees of medical compliance.ConclusionLWE conferred an MTR of 4.1 years in the iSGS cohort. The number of prior procedures preceding LWE behaved as a confounding variable. Patients who were completely or partially compliant to triple therapy appear to demonstrate increased intervals prior to recurrence.
Estimated Cost of Circulating Tumor DNA for Posttreatment Surveillance of Human Papillomavirus–Associated Oropharyngeal Cancer
Talom, Benjamin C. Kamdem, Abel, Kathryn M. Van , Daniel, MariappanJonathan , Waddle, Mark R. , Routman, David M. , Kamdem Talom, Benjamin C, Ma, Daniel M, Van Abel, Kathryn M , Routman, David M , Kowalchuk, Roman O. , Talom, Benjamin K., Ma, Daniel M.

Mayo Clinic

JAMA Network Open | January 25, 2022 | Volume: 5 | Issue: 1 | Pages: e2144783

10.1001/jamanetworkopen.2021.44783 | PMID 35076706 Get It

Oculomotor and Perceptual Measures of Visual Motion Sensitivity in Patients With Chronic Dizziness Symptoms
Zaleski-King, Ashley, Pinto, Robin, Tamaki, Chizuko, Bogle, Jamie, McCaslin, Devin, Brungart, Douglas, Bogle, Jamie M. , Zaleski-King, Ashley, Pinto, Robin, Tamaki, Chizuko, McCaslin, Devin, Brungart, Douglas S.

Mayo Clinic

Ear & Hearing | January 25, 2022 | Volume: 43 | Issue: 5 | Pages: 1515-1525

10.1097/aud.0000000000001206 | PMID 35075042 Get It

Objective: The purpose of this study was to provide empirical data describing the relationship between behavioral responses to dynamic visual motion in adults with chronic dizziness symptoms with and without clinically identifiable peripheral vestibular impairment. Design: Prospective, quasi-experimental study including individuals with chronic dizziness symptoms with identified unilateral peripheral vestibular impairment (n=27), and individuals with chronic dizziness symptoms without identified vestibular impairment (n=26). We measured (a) visual perception of verticality in a dynamic background, (b) postural displacement in a dynamic background, (c) eye movement behaviors in various visual contexts, and (d) self-rating degree of anxiety. Results: Status of peripheral vestibular function was not a significant predictor of behavioral responses to visual motion. The data show that the ability to fixate on a visual target was predictive of postural control in a dynamic visual background. Trial-to-trial variability in verticality responses and degree of self-rated anxiety were also associated with postural control. Conclusions: Apart from vestibular function, oculomotor control is important for maintaining control of whole-body motor responses during exposure to a dynamic visual stimulus. Vertical perception precision—not accuracy—may be more important for understanding real-world consequences of visual motion sensitivity. Traditional diagnostic evaluations focusing exclusively on characterizing the peripheral vestibular system may not provide insight into the behaviors associated with visual motion sensitivity.
TeleNeuroICU: Expanding the Reach of Subspecialty Neurocritical Care
Freeman, William D. , Rogers, Ashley , Freeman, William D , Rabinstein, Alejandro A.

Mayo Clinic

Seminars in Neurology | January 25, 2022 | Volume: 42 | Issue: 01 | Pages: 018-030

10.1055/s-0041-1742093 | PMID 35073589 Get It

AbstractTelemedicine is a rapidly growing field of medicine due to a combination of high-speed global telecommunication systems and accessibility of small, fast mobile computing platforms with bidirectional audiovisual camera capabilities. Teleneurology is a subset of telemedicine. TeleNeuroICU, one form of teleneurology, is the practice of virtually consulting on patients in the ICU setting with neurological and neurosurgical conditions. Given the current and future shortage of neurologists and neurointensivists, there is a high demand for TeleNeuroICU services around the globe and this is expected to increase in the future. This review summarizes the state of the art around the TeleNeuroICU practice for practitioners in the field, emerging research in this area, and new technologies and integrations that enhance the value of TeleNeuroICU to health care systems.
A pragmatic lab-based tool for risk assessment in cardiac critical care: data from the Critical Care Cardiology Trials Network (CCCTN) Registry
Patel, Siddharth M. , Alviar, Carlos L. , Baird-Zars, Vivian M., Barsness, Gregory W. , Bohula, Erin A. , Daniels, Lori B. , DeFilippis, Andrew P. , Keeley, Ellen C. , Kontos, Michael C. , Lawler, Patrick R. , Miller, P. Elliott , Park, Jeong‐Gun , Katz, Jason N. , Investigators, the CCCTN, Park, Jeong-Gun , van Diepen, Sean , Morrow, David A , Lawler, Patrick , Daniels, Lori B , Bohula, Erin A , Patel, Siddharth M , Jentzer, Jacob C. , Berg, David D. , Roswell, Robert O. , Solomon, Michael A. , Diepen, Sean van , Morrow, David A. , Investigators, the CCCTN

Mayo Clinic

European Heart Journal. Acute Cardiovascular Care | January 24, 2022 | Volume: 11 | Issue: 3 | Pages: 252-257

10.1093/ehjacc/zuac012 | PMID 35134860 Get It

Abstract Aims Contemporary cardiac intensive care unit (CICU) outcomes remain highly heterogeneous. As such, a risk-stratification tool using readily available lab data at time of CICU admission may help inform clinical decision-making. Methods and results The primary derivation cohort included 4352 consecutive CICU admissions across 25 tertiary care CICUs included in the Critical Care Cardiology Trials Network (CCCTN) Registry. Candidate lab indicators were assessed using multivariable logistic regression. An integer risk score incorporating the top independent lab indicators associated with in-hospital mortality was developed. External validation was performed in a separate CICU cohort of 9716 patients from the Mayo Clinic (Rochester, MN, USA). On multivariable analysis, lower pH [odds ratio (OR) 1.96, 95% confidence interval (CI) 1.72–2.24], higher lactate (OR 1.40, 95% CI 1.22–1.62), lower estimated glomerular filtration rate (OR 1.26, 95% CI 1.10–1.45), and lower platelets (OR 1.18, 95% CI 1.05–1.32) were the top four independent lab indicators associated with higher in-hospital mortality. Incorporated into the CCCTN Lab-Based Risk Score, these four lab indicators identified a 20-fold gradient in mortality risk with very good discrimination (C-index 0.82, 95% CI 0.80–0.84) in the derivation cohort. Validation of the risk score in a separate cohort of 3888 patients from the Registry demonstrated good performance (C-index of 0.82; 95% CI 0.80–0.84). Performance remained consistent in the external validation cohort (C-index 0.79, 95% CI 0.77–0.80). Calibration was very good in both validation cohorts (r = 0.99). Conclusion A simple integer risk score utilizing readily available lab indicators at time of CICU admission may accurately stratify in-hospital mortality risk.
A tale of two patients with hypersensitivity reactions to levothyroxine
Gansert, E, Garzon-Siatoya, W., Morgenstern‐Kaplan, Dan , Gansert, Emily , Garzon, Wendy , Gonzalez‐Estrada, Alexei

Mayo Clinic

QJM: An International Journal of Medicine | January 24, 2022 | Volume: 115 | Issue: 5 | Pages: 327-328

10.1093/qjmed/hcac029 | PMID 35080627 Get It

Honey-induced anaphylaxis in an adult
Gonzalez-Estrada, A, Jhawar, Nikita

Mayo Clinic

QJM: An International Journal of Medicine | January 24, 2022 | Volume: 115 | Issue: 5 | Pages: 325-326

10.1093/qjmed/hcac028 | PMID 35080621 Get It